Terms: = Lung cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Diagnosis
20 results:
1. lung cancer in Patients With Lynch Syndrome: Association or Coincidence?
Majeed U; Seegobin K; Lewis J; Li S; Zhao Y; Lou Y; Manochakian R
Clin Lung Cancer; 2023 Nov; 24(7):e237-e241. PubMed ID: 37336713
[TBL] [Abstract] [Full Text] [Related]
2. Successful chemotherapy with continuous immunotherapy for primary pulmonary endovascular epithelioid hemangioendothelioma: A case report.
Guo W; Zhou D; Huang H; Chen H; Wu X; Yang X; Ye H; Hong C
Medicine (Baltimore); 2023 Feb; 102(7):e32914. PubMed ID: 36800635
[TBL] [Abstract] [Full Text] [Related]
3. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract] [Full Text] [Related]
4. Metastatic rectal cancer to papillary thyroid carcinoma: a case report and review of literature.
Luo M; Huang Y; Li Y; Zhang Y
BMC Gastroenterol; 2020 May; 20(1):136. PubMed ID: 32375670
[TBL] [Abstract] [Full Text] [Related]
5. Recurrent Undifferentiated Carcinoma of the Sella in a Patient with Lynch Syndrome.
Voisin MR; Almeida JP; Perez-Ordonez B; Zadeh G
World Neurosurg; 2019 Dec; 132():219-222. PubMed ID: 31491579
[TBL] [Abstract] [Full Text] [Related]
6. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
[TBL] [Abstract] [Full Text] [Related]
7. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.
Wagner AH; Devarakonda S; Skidmore ZL; Krysiak K; Ramu A; Trani L; Kunisaki J; Masood A; Waqar SN; Spies NC; Morgensztern D; Waligorski J; Ponce J; Fulton RS; Maggi LB; Weber JD; Watson MA; O'Conor CJ; Ritter JH; Olsen RR; Cheng H; Mukhopadhyay A; Can I; Cessna MH; Oliver TG; Mardis ER; Wilson RK; Griffith M; Griffith OL; Govindan R
Nat Commun; 2018 Sep; 9(1):3787. PubMed ID: 30224629
[TBL] [Abstract] [Full Text] [Related]
8. Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.
Chedgy EC; Vandekerkhove G; Herberts C; Annala M; Donoghue AJ; Sigouros M; Ritch E; Struss W; Konomura S; Liew J; Parimi S; Vergidis J; Hurtado-Coll A; Sboner A; Fazli L; Beltran H; Chi KN; Wyatt AW
J Pathol; 2018 Oct; 246(2):244-253. PubMed ID: 30015382
[TBL] [Abstract] [Full Text] [Related]
9. Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes.
Ponz de Leon M; Pedroni M; Pezzi A; Sulce B; Roncucci L; Domati F; Rossi G; Reggiani Bonetti L
Scand J Gastroenterol; 2018 Jan; 53(1):31-37. PubMed ID: 29025352
[TBL] [Abstract] [Full Text] [Related]
10. Inherited Mutations in Women With Ovarian Carcinoma.
Norquist BM; Harrell MI; Brady MF; Walsh T; Lee MK; Gulsuner S; Bernards SS; Casadei S; Yi Q; Burger RA; Chan JK; Davidson SA; Mannel RS; DiSilvestro PA; Lankes HA; Ramirez NC; King MC; Swisher EM; Birrer MJ
JAMA Oncol; 2016 Apr; 2(4):482-90. PubMed ID: 26720728
[TBL] [Abstract] [Full Text] [Related]
11. Advances in the study of Lynch syndrome in China.
Lu JY; Sheng JQ
World J Gastroenterol; 2015 Jun; 21(22):6861-71. PubMed ID: 26078562
[TBL] [Abstract] [Full Text] [Related]
12. Asymptomatic synchronous quintuple primary cancers.
Komiyama S; Nishio E; Ichikawa R; Miyamura H; Kawamura K; Komiyama M; Nishio Y; Udagawa Y
Gynecol Obstet Invest; 2012; 74(4):324-8. PubMed ID: 22776788
[TBL] [Abstract] [Full Text] [Related]
13. cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
[TBL] [Abstract] [Full Text] [Related]
14. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract] [Full Text] [Related]
15. Pulmonary sclerosing hemangioma in a 21-year-old male with metastatic hereditary non-polyposis colorectal cancer: report of a case.
Schiergens TS; Khalil PN; Mayr D; Thasler WE; Angele MK; Hatz RA; Jauch KW; Kleespies A
World J Surg Oncol; 2011 Jun; 9():62. PubMed ID: 21645337
[TBL] [Abstract] [Full Text] [Related]
16. Genealogical tree study as screening method in the Lynch syndrome prior to genetic test.
Delgado-Plasencia L; Medina-Arana V; Barrios Del Pino Y; Fernández-Peralta A; González-Aguilera JJ
Am J Clin Oncol; 2010 Aug; 33(4):376-80. PubMed ID: 20010080
[TBL] [Abstract] [Full Text] [Related]
17. Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.
Quintás-Cardama A; Lazar AJ; Woodman SE; Kim K; Ross M; Hwu P
Nat Clin Pract Oncol; 2008 Dec; 5(12):737-40. PubMed ID: 18936790
[TBL] [Abstract] [Full Text] [Related]
18. [Fenotypical diversity of hereditary non-polyposis colorectal carcinoma. Pedigree and genetical analysis of two mutation carrier patients].
Tanyi M; Kanyári Z; Juhász B; Lukács G; Olasz J; Kámory E; Csuka O; Tóth L; Damjanovich L
Magy Seb; 2006 Dec; 59(6):411-20. PubMed ID: 17432081
[TBL] [Abstract] [Full Text] [Related]
19. Clinical characteristics of Taiwanese hereditary non-polyposis colorectal cancer kindreds.
Wei SC; Wang MH; Shieh MC; Wang CY; Wong JM
J Formos Med Assoc; 2002 Mar; 101(3):206-9. PubMed ID: 12051017
[TBL] [Abstract] [Full Text] [Related]
20. Using genetic information to make surgical decisions: report of a case of a 13-year-old boy with colon cancer.
Madlensky L; Bapat B; Redston M; Pearl R; Gallinger S; Cohen Z
Dis Colon Rectum; 1997 Feb; 40(2):240-3. PubMed ID: 9075764
[TBL] [Abstract] [Full Text] [Related]
